BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2443448)

  • 1. Two monoclonal anti-C4d reagents react with epitopes closely related to Rg:1 and Ch:1.
    Giles CM; Fielder AH; Lord DK; Robson T; O'Neill GJ
    Immunogenetics; 1987; 26(4-5):309-12. PubMed ID: 2443448
    [No Abstract]   [Full Text] [Related]  

  • 2. A monoclonal anti-C4d that demonstrates a specificity related to anti-Ch.
    Giles CM; Ford DS
    Transfusion; 1986; 26(4):370-4. PubMed ID: 3523873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
    Giles CM; Davies KA; Walport MJ
    Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Chido determinants detected on the B5Rg+ allotype of human C4: their expression in Ch-typed donors and families.
    Giles CM
    Hum Immunol; 1987 Feb; 18(2):111-22. PubMed ID: 2435683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C4 reference typing report.
    Mauff G; Brenden M; Braun-Stilwell M; Doxiadis G; Giles CM; Hauptmann G; Rittner C; Schneider PM; Stradmann-Bellinghausen B; Uring-Lambert B
    Complement Inflamm; 1990; 7(4-6):193-212. PubMed ID: 1708323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model.
    Giles CM; Uring-Lambert B; Goetz J; Hauptmann G; Fielder AH; Ollier W; Rittner C; Robson T
    Immunogenetics; 1988; 27(6):442-8. PubMed ID: 2453461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
    Taillon-Miller PA; Shreffler DC
    J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesis.
    Mathias P; Shreffler DC; Cooper NR; Ogata RT
    J Immunol; 1990 Jan; 144(2):607-9. PubMed ID: 2295802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
    Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
    J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d and the fate of organ allografts.
    Platt JL
    J Am Soc Nephrol; 2002 Sep; 13(9):2417-9. PubMed ID: 12191987
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphism of the human complement component C4.
    Campbell RD; Dunham I; Kendall E; Sargent CA
    Exp Clin Immunogenet; 1990; 7(1):69-84. PubMed ID: 1971760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic control of the antibody response to allotypes of murine C4.
    Spinella DG; Roper LA; Passmore HC
    Immunogenetics; 1984; 19(1):87-92. PubMed ID: 6693139
    [No Abstract]   [Full Text] [Related]  

  • 14. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.
    Tilley CA; Romans DG; Crookston MC
    Nature; 1978 Dec; 276(5689):713-5. PubMed ID: 83538
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA haplotypes with C4B5; evidence for further allelic heterogeneity.
    Hing SN; Giles CM; Fielder AH; Batchelor JR
    Immunogenetics; 1986; 23(3):151-5. PubMed ID: 3485571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sequence differences between Chido and Rodgers variants of tryptic C4d of the human complement system.
    Hellman U; Eggertsen G; Lundwall A; Engström A; Sjöquist J
    FEBS Lett; 1984 May; 170(2):254-8. PubMed ID: 6723966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoelectrophoretic analysis of C4 split products expressing D but not C epitopes: influence of storage, Ca2+ and Ca2+-chelating agents.
    Petersen NE; Folkersen J; Teisner B; Svehag SE
    Complement; 1985; 2(2-3):147-55. PubMed ID: 2417781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4: Rodgers and Chido typing.
    Giles CM
    Complement Inflamm; 1990; 7(4-6):213-7. PubMed ID: 1708324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.
    Wolbink GJ; Bollen J; Baars JW; ten Berge RJ; Swaak AJ; Paardekooper J; Hack CE
    J Immunol Methods; 1993 Jul; 163(1):67-76. PubMed ID: 7687639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.